Literature DB >> 11858357

Fibromyalgia in Italian patients with primary Sjögren's syndrome.

Pierantonio Ostuni1, Costantino Botsios, Paolo Sfriso, Leonardo Punzi, Fulvia Chieco-Bianchi, Luca Semerano, Chiaza Grava, Silvano Todesco.   

Abstract

OBJECTIVE: To assess the prevalence of fibromyalgia in primary Sjögren's syndrome and to evaluate the clinical differences between patients affected with both primary fibromyalgia and primary Sjögren's syndrome and those affected only with primary fibromyalgia.
METHODS: Clinical features of fibromyalgia were evaluated in 100 consecutive outpatients with primary Sjögren's syndrome and, as controls, in 90 patients with non-insulin-dependent diabetes mellitus, in 75 patients with primary fibromyalgia and in 30 healthy subjects.
RESULTS: Fibromyalgia was recorded in 22% of patients with primary Sjögren's syndrome, in 12.2% with diabetes and in 3.3% of healthy controls. In the primary Sjögren's syndrome group the prevalence was significantly higher than in healthy controls (P < 0.01), but not significantly different than in diabetes. Moreover, primary Sjögren's syndrome with fibromyalgia and primary fibromyalgia patients did not differ with respect to the number of tender points, while the mean pain threshold was lower in the latter (P = 0.05). Purpura, hypergammaglobulinemia, rheumatoid factor, and a focus score > or = 1 on lip biopsy were significantly more frequent in primary Sjögren's syndrome patients without than with fibromyalgia.
CONCLUSIONS: As recently reported by other authors, our study confirms the moderate increase of fibromyalgia prevalence in primary Sjögren's syndrome. Typical fibromyalgic findings are quite similar to those of primary fibromyalgia, but surprisingly, primary Sjögren's syndrome patients with fibromyalgia show a less severe global involvement than those with primary Sjögren's syndrome alone.

Entities:  

Mesh:

Year:  2002        PMID: 11858357     DOI: 10.1016/s1297-319x(01)00341-4

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  7 in total

Review 1.  Topical and systemic medications for the treatment of primary Sjögren's syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Antoni Sisó-Almirall; Xavier Bosch; Athanasios G Tzioufas
Journal:  Nat Rev Rheumatol       Date:  2012-05-01       Impact factor: 20.543

2.  [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

Authors:  C Sommer; W Häuser; K Gerhold; P Joraschky; F Petzke; T Tölle; N Uçeyler; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

3.  Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity.

Authors:  Fausto Salaffi; Rossella De Angelis; Marina Carotti; Marwin Gutierrez; Piercarlo Sarzi-Puttini; Fabiola Atzeni
Journal:  Rheumatol Int       Date:  2014-02-08       Impact factor: 2.631

Review 4.  Are patients with systemic lupus erythematosus at increased risk for fibromyalgia?

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.592

Review 5.  Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly.

Authors:  Kristine P Ng; David A Isenberg
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 6.  Clinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue Diseases.

Authors:  Tsuyoshi Kasama; Airi Maeoka; Nao Oguro
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-01-18

7.  Ambroxol for the treatment of fibromyalgia: science or fiction?

Authors:  Kai-Uwe Kern; Myriam Schwickert
Journal:  J Pain Res       Date:  2017-08-16       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.